Skip to main content
Have a personal or library account? Click to login
BDH2 Inhibits Lung Adenocarcinoma Metastasis by Promoting Ferroptosis Cover

BDH2 Inhibits Lung Adenocarcinoma Metastasis by Promoting Ferroptosis

Archivum Immunologiae et Therapiae Experimentalis
Volume 74 (2026): Issue 1 (January 2026)
By: Qiao Yang,  Lin Tian,  Xiaodong Chen,  Xiong Mei,  Yongli Nie and  Jun Chen  
Open Access
|Apr 2026
Figures & tables

Figures & Tables

Fig 1.

BDH2 inhibits migration, invasion, and EMT of LUAD cells. (A) Western blot analysis of BDH2 protein expression in A549 and PC9 cells following transfection with empty vector (pcDNA) or BDH2-overexpressing plasmid (pcDNA-BDH2). GAPDH was used as a loading control. Quantification of BDH2 protein levels is shown below. (B) Representative images of Transwell migration and invasion assays performed in A549 and PC9 cells after transfection with pcDNA or pcDNA-BDH2. Quantitative analysis of migrated and invaded cells is presented in the bar graphs. Data are presented as mean ± SD. ***p < 0.001. EMT, epithelial–mesenchymal transition; LUAD, lung adenocarcinoma; SD, standard deviation.

Fig 2.

BDH2 suppresses migration and invasion of LUAD cells by promoting ferroptosis. (A) Measurement of intracellular Fe2+ levels in A549 and PC9 cells under different conditions: Blank, pcDNA, pcDNA-BDH2, pcDNA-BDH2 + ferroptosis inhibitor (Fer-1), and pcDNA-BDH2 + ferroptosis inducer (Erastin). (B) Measurement of MDA levels in A549 and PC9 cells under the same experimental conditions. (C) Western blot analysis of ACSL4 and GPX4 protein expression in A549 and PC9 cells across different groups. GAPDH was used as a loading control. Quantification of protein expression levels is shown below. Data are presented as mean ± SD. ***p < 0.001 vs control; ###p < 0.001 vs pcDNA-BDH2 group. BDH2, 3-Hydroxybutyrate dehydrogenase 2; LUAD, lung adenocarcinoma; MDA, malondialdehyde; SD, standard deviation.

Fig 3.

BDH2 regulates the Nrf2/HO-1 axis in LUAD cells. Western blot analysis of Nrf2 and HO-1 protein expression in A549 and PC9 cells after transfection with pcDNA or BDH2-overexpressing plasmid (pcDNA-BDH2). GAPDH was used as a loading control. Quantitative analysis of protein expression levels is shown in the bar graphs. Data are presented as mean ± SD. ***p < 0.001 vs control. LUAD, lung adenocarcinoma; SD, standard deviation.

Fig 4.

BDH2 inhibits tumor metastasis in vivo by promoting ferroptosis in LUAD cells. (A) Representative images of xenograft tumors derived from A549 cells transfected with pcDNA, pcDNA-BDH2, or pcDNA-BDH2 combined with ferroptosis inhibitor (Fer-1). Tumor growth curves and tumor weights are shown in the corresponding graphs. (B) Representative hematoxylin and eosin (H&E) staining of tissue sections from nude mice in different groups, used to evaluate metastatic lesions. Data are presented as mean ± SD. ***p < 0.001 vs control; ###p < 0.001 vs pcDNA-BDH2 group. LUAD, lung adenocarcinoma; SD, standard deviation.
DOI: https://doi.org/10.2478/aite-2026-0012 | Journal eISSN: 1661-4917
Journal RSS Feed
Language: English
Submitted on: Oct 14, 2025
Accepted on: Feb 6, 2026
Published on: Apr 9, 2026
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
BDH2,
lung adenocarcinoma,
ferroptosis,
metastasis,
Nrf2/HO-1 signaling,
SLC7A11
Related subjects:
Medicine,
Basic medical science,
Biochemistry,
Immunology,
Clinical medicine,
Clinical medicine, other,
Clinical chemistry

© 2026 Qiao Yang, Lin Tian, Xiaodong Chen, Xiong Mei, Yongli Nie, Jun Chen, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 74 (2026): Issue 1 (January 2026)
Previous article
Next article